Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04674267 · ClinicalTrials.gov registry record · NA
Resilience and Equity in Aging, Cancer, and Health (REACH)
A NA study of Pancreatic Cancer and Gastric Cancer, sponsored by Dana-Farber Cancer Institute.
- Recruiting
- Registry status
- NA
- Development phase
- 257
- Enrollment target
- 1
- Study location
NCT04674267 is a NA study of Pancreatic Cancer and Gastric Cancer that is actively recruiting participants, run by Dana-Farber Cancer Institute. The registered enrollment target is 257 participants, below the 392-participant average among 278 other Pancreatic Cancer trials with a reported enrollment target (34% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04674267, a NA study of Pancreatic Cancer and Gastric Cancer, is actively recruiting participants, sponsored by Dana-Farber Cancer Institute.
- RECRUITING
- Registry status
- NA
- Development phase
- 257 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this multi-phase research study is to understand how consultation of cancer care with a geriatrician can best improve outcomes for older adults with gastrointestinal malignancies.
Conditions Studied
Interventions
- OTHER Phase 2 Intervention - Geriatric Co-Management
Study Locations (1)
Massachusetts
- Dana-Farber Cancer Institute - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 257 participants |
| Start Date | 2022-01-18 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04674267
The ClinicalTrials.gov registry entry for NCT04674267 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 257 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 392-participant average among 278 other Pancreatic Cancer trials with a reported enrollment target (34% lower). The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.
The record links to 6 conditions, with Pancreatic Cancer appearing as the primary indexed condition, and to 1 intervention - of which Phase 2 Intervention - Geriatric Co-Management is the first listed.
NCT04674267 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04674267 about?
NCT04674267 is a clinical study titled "Resilience and Equity in Aging, Cancer, and Health (REACH)". The purpose of this multi-phase research study is to understand how consultation of cancer care with a geriatrician can best improve outcomes for older adults with gastrointestinal malignancies.
What is the current status of trial NCT04674267?
This trial is currently recruiting. It is a NA study. The enrollment target is 257 participants. The study started on 2022-01-18. Estimated completion is 2026-12-31.
What conditions does trial NCT04674267 study?
This clinical trial studies the following conditions: Pancreatic Cancer, Gastric Cancer, Esophageal Cancer, Colon Cancer, Rectal Cancer.
What interventions are being tested in trial NCT04674267?
The interventions under investigation include: Phase 2 Intervention - Geriatric Co-Management (OTHER).
Who is sponsoring clinical trial NCT04674267?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04674267 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pancreatic Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Alpha Radiation Emitters Device for the Treatment of Pancreatic Cancer With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer
RECRUITING · NA
-
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
RECRUITING · NA
-
EUS Examination Using EndoSound Vision System vs. Standard Echoendoscope
RECRUITING · NA
-
Computed Tomography in Diagnosing Patients With Pancreatic or Hepatobiliary Cancer
RECRUITING · NA
-
Support Through Remote Observation and Nutrition Guidance Program (STRONG-PCS)
RECRUITING · NA
-
GENOCARE: A Prospective, Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual Care
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.